The treatment of psoriasis and psoriatic arthritis: An interdisciplinary approach - 09/08/11
, Eric M. Ruderman, MD b
Correspondence to: Kenneth B. Gordon, MD, Division of Dermatology, Evanston Northwestern Healthcare, 9977 Woods Dr, Skokie, IL, 60077.Skokie and Chicago, Illinois
Abstract |
Psoriatic arthritis is a common inflammatory arthritis associated with psoriasis, occurring in 5% to 40% of patients with cutaneous disease. Recently, there has been an increased appreciation of the need to use an integrated approach to these 2 diseases, considering both entities when determining therapeutic choices. In this review, the available therapeutic options for psoriatic arthritis are considered, along with the potential benefit that these medications may have for cutaneous psoriasis. Finally, a conceptual model for the therapy of psoriasis and psoriatic arthritis, the Four Quadrant Model, is presented as a simplified framework to use when considering treatment for psoriatic disease.
Le texte complet de cet article est disponible en PDF.Plan
| Supported by Amgen Inc and Wyeth Research. This review was investigator initiated. Financial support for the manuscript was provided by Amgen; all other aspects were performed independently of Amgen. Conflicts of interest: Dr Gordon has received research support and honoraria from the following companies: Abbott, Amgen, Biogen, Centocor, and Genentech. He received an honorarium from Amgen for this manuscript work. Dr Ruderman has received research grants from Abbott Immunology, Amgen, Bristol Meyers Squibb, Centocor, Genentech, IDEC, Merck, and Pfizer. He has consulted for Abbott Immunology, Amgen, Bristol Meyers Squibb, Genentech, Merck, and Wyeth, and has served on speakers’ bureaus for Abbott Immunology, Amgen, Centocor, Merck, Pfizer, and Wyeth. He does not own stock in any of these companies. Reprints not available from the authors. |
Vol 54 - N° 3S2
P. S85-S91 - mars 2006 Retour au numéro
Article précédent
- A European perspective on the challenges of managing psoriasis
- Rosita Saraceno, Christopher E.M. Griffiths
- Etanercept monotherapy in patients with psoriasis: A summary of safety, based on an integrated multistudy database
- Alice B. Gottlieb, Craig L. Leonardi, Bernard S. Goffe, Jean-Paul Ortonne, Peter C.M. van der Kerkhof, Ralph Zitnik, Arline Nakanishi, Angelika Jahreis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?